Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Director/PDMR Shareholding

23 Mar 2023 15:00

RNS Number : 0580U
Phoenix Group Holdings PLC
23 March 2023
 

Phoenix Group Holdings plc (the "Company")

Exercise of nil-cost options under the Phoenix Group Holdings plc Long Term Incentive Plan (the "LTIP") and Deferred Bonus Share Scheme (the "DBSS").

 

The Company announces that on 22 March 2023, the following Persons Discharging Managerial Responsibilities "PDMRs" exercised their nil-cost options over ordinary shares of £0.10 each in the Company under the LTIP and DBSS granted on 13 March 2020. 

 

LTIP

 

Vesting of these options was subject to criteria relating to the Company's performance over a three-year performance period to 31 December 2022. The options become exercisable for up to 7 years from 13 March 2023.

 

 

Name

Title

Number of ordinary shares acquired of £0.10 each on exercise of options

Claire Hawkins

Corporate Affairs & Investor Relations Director

8432

 

The income tax and national insurance liabilities arising on the exercise of the options were self-funded by Claire Hawkins.

DBSS

 

Vesting of these options was subject to a three-year holding period in respect of the deferred bonus for the 2019 financial year to 31 December 2022. The options become exercisable for up to 6 months with effect from 13 March 2023.

 

Name

Title

Number of ordinary shares acquired of £0.10 each on exercise of options

Claire Hawkins

Corporate Affairs & Investor Relations Director

8407

 

The income tax and national insurance liabilities arising on the exercise of the options were self-funded by Claire Hawkins.

 

 

Notification and public disclosure of transactions by persons discharging managerial

 

The Notification of Dealing Forms for each PDMR can be found below. This announcement is made in accordance with the UK Markets Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018). 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Claire Hawkins

2

 

Reason for the notification

 

a)

 

Position/status

 

Corporate Affairs & Investor Relations Director/PDMR

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Phoenix Group Holdings plc

b)

 

LEI

 

2138001P49OLAEU33T68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Phoenix Group Holdings plc ordinary shares of £0.10

 

 

GB00BGXQNP29

b)

 

Nature of the transaction

 

Exercise of options under the Company's DBSS & LTIP (self-funded tax payment)  

c)

 

Price(s) and volume(s)

 

 

 

Item

Price(s)

Volume(s)

Exercise of LTIP Options

nil

8432

Exercise of DBSS Options

nil

8407

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A

e)

 

Date of the transaction

22 March 2023

f)

Place of the transaction

Outside a trading venue

Enquiries:

Media Douglas Campbell

Teneo

+44 (0)7753 136628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0) 204 559 3031 

Investors Claire Hawkins, Corporate Affairs Director, Phoenix Group+44 (0) 204 559 3161 

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0) 204 559 3145 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZXLFLXXLFBBZ
Date   Source Headline
3rd Jul 20233:30 pmRNSTotal Voting Rights
30th Jun 202311:30 amRNSPublication of a Prospectus
16th Jun 20233:01 pmRNSDirector Declaration
12th Jun 20231:30 pmRNSBlock Listing Return
7th Jun 20238:38 amRNSDirector/PDMR Shareholding
1st Jun 20231:24 pmRNSBlock Listing Application
1st Jun 20231:00 pmRNSTotal Voting Rights
16th May 202312:10 pmRNSDirector/PDMR Shareholding
11th May 20236:00 pmRNSDirectorate Change
10th May 20234:06 pmRNSDirector/PDMR Shareholding
4th May 20233:35 pmRNSHolding(s) in Company
4th May 20232:19 pmRNSResult of AGM
2nd May 20233:00 pmRNSTotal Voting Rights
6th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSTotal Voting Rights
3rd Apr 20238:02 amRNSAcquisition
30th Mar 20232:00 pmRNSDirector/PDMR Shareholding
28th Mar 20234:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20233:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20235:45 pmRNSNotice of AGM
22nd Mar 20233:00 pmRNSDirector/PDMR Shareholding
20th Mar 20235:00 pmRNSDirector/PDMR Shareholding
15th Mar 20235:30 pmRNSDirector/PDMR Shareholding
13th Mar 20233:00 pmRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNS2022 Annual Financial Report
10th Mar 20239:31 amRNSDirectorate Change - Replacement
10th Mar 20239:00 amRNSDirectorate Change
8th Mar 20234:00 pmRNSDirector/PDMR Shareholding
1st Mar 20232:00 pmRNSTotal Voting Rights
7th Feb 20233:45 pmRNSMiscellaneous - PGH/TCS Extension of Partnership
7th Feb 20232:30 pmRNSDirector/PDMR Shareholding
1st Feb 20232:00 pmRNSTotal Voting Rights
6th Jan 20234:30 pmRNSDirector/PDMR Shareholding
30th Dec 20221:00 pmRNSTotal Voting Rights
12th Dec 20224:30 pmRNSBlock listing Interim Review
7th Dec 20224:45 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSTrading Statement
30th Nov 20222:00 pmRNSTotal Voting Rights
8th Nov 20225:30 pmRNSDirector/PDMR Shareholding
31st Oct 20226:00 pmRNSTotal Voting Rights
12th Oct 20224:00 pmRNSDirectorate Change
6th Oct 20224:30 pmRNSDirector/PDMR Shareholding
6th Oct 20224:30 pmRNSDirector/PDMR Shareholding
4th Oct 20224:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:30 pmRNSTotal Voting Rights
14th Sep 20224:30 pmRNSDirector/PDMR Shareholding
9th Sep 202211:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.